Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Endogenous NMDA receptor antagonist.
PP2A inhibitor.
Lincosamide; peptidyl transferase inhibitor, pr...
Sialic-acid sensing lectin.
Synthesis impurity
Endogenous peptide hormone, involved in water h...
DHF reductase inhibitor.
Caffeic acid derivative.
EGFR (WT, T790M) inhibitor.
Taxane synthesis intermediate.
Taxane found in species of Taxus; potential mic...
TRPV4 agonist
Benzamide; HDAC1 inhibitor.
Carotenoid found in shrimp, salmon, and algae.<...
GSK-3 and CDK inhibitor.
Aminoglycoside; protein translation inhibitor, ...
Laminin-derived nonapeptide.
CD73 inhibitor
SIRT1/2 inhibitor, indirect p53 activator.